Cargando…

Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel

BACKGROUND: The identification of driver mutations has greatly promoted the precise diagnosis and treatment of non-small cell lung cancer (NSCLC), but there is lack of targeted sequencing panels specifically designed and applied to Chinese NSCLC patients. This study aimed to design and validate of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jing, Wu, Yang, Chen, Min-Jiang, Xu, Yan, Zhong, Wei, Wang, Meng-Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840037/ https://www.ncbi.nlm.nih.gov/pubmed/36647494 http://dx.doi.org/10.21037/jtd-22-909

Ejemplares similares

Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma
por: Li, Ying, et al.
Publicado: (2020)

Genomic Profiling of Driver Gene Mutations in Chinese Patients With Non-Small Cell Lung Cancer
por: Meng, Hongxue, et al.
Publicado: (2019)

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer
por: Zhang, Manman, et al.
Publicado: (2020)

Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
por: Wang, Rui, et al.
Publicado: (2015)

Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancer
por: Park, Sehhoon, et al.
Publicado: (2021)

Genetic Mutation Analysis in Small Cell Lung Cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features
por: Jin, Wang, et al.
Publicado: (2021)

Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer
por: Daoud, Alia, et al.
Publicado: (2017)

Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer
por: Chen, Minjiang, et al.
Publicado: (2019)

Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method
por: Tang, Yuan, et al.
Publicado: (2020)

A novel mutation panel for predicting etoposide resistance in small-cell lung cancer
por: Qiu, Zhengang, et al.
Publicado: (2019)

A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations
por: Li, Wanlin, et al.
Publicado: (2021)

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
por: Liang, Hongge, et al.
Publicado: (2022)

Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology
por: DiBardino, David M., et al.
Publicado: (2017)

Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis
por: Zeng, Chun, et al.
Publicado: (2021)

Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
por: LaDuca, Holly, et al.
Publicado: (2017)

Traditional Chinese Medicine Syndromes are Associated with Driver Gene Mutations and Clinical Characteristics in Patients with Lung Adenocarcinoma
por: Yang, Jili, et al.
Publicado: (2022)

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion
por: Chu, Quincy S.
Publicado: (2020)

Exome sequencing identifies frequent mutation of MLL2 in non–small cell lung carcinoma from Chinese patients
por: Yin, Shanye, et al.
Publicado: (2014)

Application of targeted panel sequencing and whole exome sequencing for 76 Chinese families with retinitis pigmentosa
por: Dan, Handong, et al.
Publicado: (2020)

Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer
por: Guo, Yijia, et al.
Publicado: (2019)

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
por: Wang, Zhijie, et al.
Publicado: (2019)

Clinical Genotyping of Non–Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes()
por: Tafe, Laura J., et al.
Publicado: (2016)

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer
por: Si, Xiaoyan, et al.
Publicado: (2020)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer
por: Bruggemann, Liana, et al.
Publicado: (2023)

Targeted next-generation sequencing extends the mutational spectrums for OPA1 mutations in Chinese families with optic atrophy
por: Wang, Yuwei, et al.
Publicado: (2019)

HER2 mutations in Chinese patients with non-small cell lung cancer
por: Song, Zhengbo, et al.
Publicado: (2016)

Driver gene alterations profiling of Chinese non‐small cell lung cancer and the effects of co‐occurring alterations on immunotherapy
por: Sun, Shengjie, et al.
Publicado: (2021)

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma
por: Mack, Philip C, et al.
Publicado: (2022)

Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of China
por: Gou, Lan-Ying, et al.
Publicado: (2014)

Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
por: Chevallier, Mathieu, et al.
Publicado: (2021)

The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation
por: Cui, Jinfeng, et al.
Publicado: (2022)

To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations
por: Cai, Ruoxue, et al.
Publicado: (2023)

Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation
por: Ding, Xi, et al.
Publicado: (2017)

Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing
por: Su, Shan, et al.
Publicado: (2019)

OTHR-11. Comprehensive Analysis of Driver Mutation Profile in a Cohort of Lung Cancer Patients Using Targeted Gene Panel Analysis with Focus on Brain Metastatic Disease
por: Kazarian, Marina, et al.
Publicado: (2021)

Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer
por: Jia, Yijun, et al.
Publicado: (2017)

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
por: Ding, Xiao-Xiao, et al.
Publicado: (2017)

Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing
por: Yang, Qin, et al.
Publicado: (2020)

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment
por: Jakobsen, Jan Nyrop, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_93mj7c4p4udfvmr4nipoq8vokk